Evaluation of the risk of hepatitis from clotting factor concentrates.
Fricke
W A
WA
Food and Drug Administration, Bethesda, MD 20892.
D000410:Alanine Transaminase / Q000097:blood; D001779:Blood Coagulation Factors / Q000009:adverse effects*; D004340:Drug Contamination; D006525:Hepatitis, Viral, Human / Q000635:transmission*; D006801:Humans; D012307:Risk Factors; D012449:Safety
D001779:Blood Coagulation Factors; D000410:Alanine Transaminase